BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sigterman KE, van Pinxteren B, Bonis PA, Lau J, Numans ME. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev. 2013;CD002095. [PMID: 23728637 DOI: 10.1002/14651858.cd002095.pub5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Wilsdon TD, Hendrix I, Thynne TR, Mangoni AA. Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults. Drugs Aging 2017;34:265-87. [PMID: 28220380 DOI: 10.1007/s40266-017-0442-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
2 Savarino V, Pace F, Scarpignato C; Esoxx Study Group. Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation. Aliment Pharmacol Ther 2017;45:631-42. [PMID: 28116754 DOI: 10.1111/apt.13914] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
3 de Bortoli N, Tolone S, Frazzoni M, Martinucci I, Sgherri G, Albano E, Ceccarelli L, Stasi C, Bellini M, Savarino V, Savarino EV, Marchi S. Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders. Ann Gastroenterol 2018;31:639-48. [PMID: 30386113 DOI: 10.20524/aog.2018.0314] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
4 Sandhu DS, Fass R. Current Trends in the Management of Gastroesophageal Reflux Disease. Gut Liver 2018;12:7-16. [PMID: 28427116 DOI: 10.5009/gnl16615] [Cited by in Crossref: 63] [Cited by in F6Publishing: 38] [Article Influence: 15.8] [Reference Citation Analysis]
5 Sun QH, Wang HY, Sun SD, Zhang X, Zhang H. Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial. World J Gastroenterol 2019; 25(17): 2110-2121 [PMID: 31114137 DOI: 10.3748/wjg.v25.i17.2110] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
6 Iwakiri K, Kinoshita Y, Habu Y, Oshima T, Manabe N, Fujiwara Y, Nagahara A, Kawamura O, Iwakiri R, Ozawa S, Ashida K, Ohara S, Kashiwagi H, Adachi K, Higuchi K, Miwa H, Fujimoto K, Kusano M, Hoshihara Y, Kawano T, Haruma K, Hongo M, Sugano K, Watanabe M, Shimosegawa T. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J Gastroenterol. 2016;51:751-767. [PMID: 27325300 DOI: 10.1007/s00535-016-1227-8] [Cited by in Crossref: 142] [Cited by in F6Publishing: 115] [Article Influence: 23.7] [Reference Citation Analysis]
7 Rettura F, Bronzini F, Campigotto M, Lambiase C, Pancetti A, Berti G, Marchi S, de Bortoli N, Zerbib F, Savarino E, Bellini M. Refractory Gastroesophageal Reflux Disease: A Management Update. Front Med (Lausanne) 2021;8:765061. [PMID: 34790683 DOI: 10.3389/fmed.2021.765061] [Reference Citation Analysis]
8 Tilak A, Ramirez AG, Turrentine FE, Sohn MW, Jones RS. Preoperative Gastroesophageal Reflux Disorder Is Associated With Increased Morbidity in Patients Undergoing Abdominal Surgery. J Surg Res 2018;232:587-94. [PMID: 30463778 DOI: 10.1016/j.jss.2018.07.051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Singh A, Ford AM, McMichael J, Gabbard S. Role of Neuromodulators for the Management of Post-Gastric-Fundoplication Dyspepsia: A Retrospective Series. Cureus 2021;13:e18343. [PMID: 34725600 DOI: 10.7759/cureus.18343] [Reference Citation Analysis]
10 Boardman HF, Heeley G. The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors. Int J Clin Pharm 2015;37:709-16. [PMID: 26100836 DOI: 10.1007/s11096-015-0150-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
11 Dong C, Lee YH, Tan TY, Yao CC, Wei JC. Correspondence to proton pump inhibitors and risk of colorectal cancer. Gut 2021:gutjnl-2021-326139. [PMID: 34857615 DOI: 10.1136/gutjnl-2021-326139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 di Pietro M, Fitzgerald RC. Research advances in esophageal diseases: bench to bedside. F1000Prime Rep. 2013;5:44. [PMID: 24167725 DOI: 10.12703/p5-44] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
13 Li D, Zhu L, Liu D. Acupuncture for refractory gastro-oesophageal reflux disease: a systematic review and meta-analysis protocol. BMJ Open 2019;9:e030713. [PMID: 31455714 DOI: 10.1136/bmjopen-2019-030713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Lin CW, Li XR. Surgical treatment of gastroesophageal reflux disease. Shijie Huaren Xiaohua Zazhi 2015; 23(32): 5093-5100 [DOI: 10.11569/wcjd.v23.i32.5093] [Reference Citation Analysis]
15 Niikura R, Yamada A, Hirata Y, Hayakawa Y, Takahashi A, Shinozaki T, Takeuchi Y, Fujishiro M, Koike K. Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease. Intern Med 2018;57:2443-50. [PMID: 29607951 DOI: 10.2169/internalmedicine.0492-17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
16 Miftahussurur M, Doohan D, Nusi IA, Adi P, Rezkitha YAA, Waskito LA, Fauzia KA, Bramantoro T, Maimunah U, Thamrin H, Masithah SI, Sukadiono S, Uchida T, Lusida MI, Yamaoka Y. Gastroesophageal reflux disease in an area with low Helicobacter pylori infection prevalence. PLoS One 2018;13:e0205644. [PMID: 30427843 DOI: 10.1371/journal.pone.0205644] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
17 Scarpellini E, Ang D, Pauwels A, De Santis A, Vanuytsel T, Tack J. Management of refractory typical GERD symptoms. Nat Rev Gastroenterol Hepatol. 2016;13:281-294. [PMID: 27075264 DOI: 10.1038/nrgastro.2016.50] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
18 Boarino V, Raguzzi I, Marocchi M, Merighi A. Symptomatic response to GERDOFF® in patients with gastro-esophageal reflux disease and poor response to alginates: an exploratory, post-market, open-label study. Turk J Gastroenterol 2020;31:466-73. [PMID: 32721918 DOI: 10.5152/tjg.2020.19327] [Reference Citation Analysis]
19 MacFarlane B, Matthews A, Bergin J. Non-prescription treatment of NSAID induced GORD by Australian pharmacies: a national simulated patient study. Int J Clin Pharm 2015;37:851-6. [PMID: 25972205 DOI: 10.1007/s11096-015-0129-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
20 Park CH, Seo SI, Kim JS, Kang SH, Kim BJ, Choi YJ, Byun HJ, Yoon JH, Lee SK. Treatment of non-erosive reflux disease and dynamics of the esophageal microbiome: a prospective multicenter study. Sci Rep 2020;10:15154. [PMID: 32938975 DOI: 10.1038/s41598-020-72082-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Bhatia SJ, Makharia GK, Abraham P, Bhat N, Kumar A, Reddy DN, Ghoshal UC, Ahuja V, Rao GV, Devadas K, Dutta AK, Jain A, Kedia S, Dama R, Kalapala R, Alvares JF, Dadhich S, Dixit VK, Goenka MK, Goswami BD, Issar SK, Leelakrishnan V, Mallath MK, Mathew P, Mathew P, Nandwani S, Pai CG, Peter L, Prasad AVS, Singh D, Sodhi JS, Sud R, Venkataraman J, Midha V, Bapaye A, Dutta U, Jain AK, Kochhar R, Puri AS, Singh SP, Shimpi L, Sood A, Wadhwa RT. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol 2019;38:411-40. [PMID: 31802441 DOI: 10.1007/s12664-019-00979-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
22 Chen L, Chen Y, Li B. The efficacy and safety of proton-pump inhibitors in treating patients with non-erosive reflux disease: a network meta-analysis. Sci Rep 2016;6:32126. [PMID: 27581096 DOI: 10.1038/srep32126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
23 Rosen R, Vandenplas Y, Singendonk M, Cabana M, DiLorenzo C, Gottrand F, Gupta S, Langendam M, Staiano A, Thapar N, Tipnis N, Tabbers M. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66:516-554. [PMID: 29470322 DOI: 10.1097/mpg.0000000000001889] [Cited by in Crossref: 258] [Cited by in F6Publishing: 74] [Article Influence: 86.0] [Reference Citation Analysis]
24 Zhang C, Kwong JS, Yuan RX, Chen H, Xu C, Wang YP, Yang GL, Yan JZ, Peng L, Zeng XT, Weng H, Luo J, Niu YM. Effectiveness and Tolerability of Different Recommended Doses of PPIs and H2RAs in GERD: Network Meta-Analysis and GRADE system. Sci Rep. 2017;7:41021. [PMID: 28102361 DOI: 10.1038/srep41021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
25 Strand DS, Kim D, Peura DA. 25 Years of Proton Pump Inhibitors: A Comprehensive Review. Gut Liver. 2017;11:27-37. [PMID: 27840364 DOI: 10.5009/gnl15502] [Cited by in Crossref: 147] [Cited by in F6Publishing: 119] [Article Influence: 29.4] [Reference Citation Analysis]
26 Bor S, Kalkan İH, Çelebi A, Dinçer D, Akyüz F, Dettmar P, Özen H. Alginates: From the ocean to gastroesophageal reflux disease treatment. Turk J Gastroenterol 2019;30:109-36. [PMID: 31624050 DOI: 10.5152/tjg.2019.19677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
27 Peura DA, Le Moigne A, Wassel H, Pollack C. Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials. BMC Gastroenterol 2018;18:69. [PMID: 29788903 DOI: 10.1186/s12876-018-0790-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Jamshed S, Bhagavathula AS, Zeeshan Qadar SM, Alauddin U, Shamim S, Hasan S. Cost-effective Analysis of Proton Pump Inhibitors in Long-term Management of Gastroesophageal Reflux Disease: A Narrative Review. Hosp Pharm 2020;55:292-305. [PMID: 32999499 DOI: 10.1177/0018578719893378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
29 Fröhlich G, Fröhlich H. [Upper abdominal pain: a frequent and multifaceted leading symptom in primary care internal medicine]. Internist (Berl) 2021;62:3-16. [PMID: 33331949 DOI: 10.1007/s00108-020-00917-7] [Reference Citation Analysis]
30 Ang D, How CH, Ang TL. Persistent gastro-oesophageal reflux symptoms despite proton pump inhibitor therapy. Singapore Med J 2016;57:546-51. [PMID: 27779277 DOI: 10.11622/smedj.2016167] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
31 Takenaka R, Okada H, Kawano S, Komazawa Y, Yoshinaga F, Nagata S, Inoue M, Komatsu H, Onogawa S, Kushiyama Y, Mukai S, Todo H, Okanobu H, Manabe N, Tanaka S, Haruma K, Kinoshita Y. Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux disease. World J Gastroenterol 2016; 22(23): 5430-5435 [PMID: 27340360 DOI: 10.3748/wjg.v22.i23.5430] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
32 Kanno T, Moayyedi P. Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem. Curr Gastroenterol Rep 2019;21:65. [PMID: 31807948 DOI: 10.1007/s11894-019-0732-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Jung DH, Huh CW, Lee SK, Park JC, Shin SK, Lee YC. A Systematic Review and Meta-analysis of Randomized Control Trials: Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2021;27:165-75. [PMID: 33795539 DOI: 10.5056/jnm20161] [Reference Citation Analysis]
34 Jung HK, Tae CH, Song KH, Kang SJ, Park JK, Gong EJ, Shin JE, Lim HC, Lee SK, Jung DH, Choi YJ, Seo SI, Kim JS, Lee JM, Kim BJ, Kang SH, Park CH, Choi SC, Kwon JG, Park KS, Park MI, Lee TH, Kim SY, Cho YS, Lee HH, Jung KW, Kim DH, Moon HS, Miwa H, Chen CL, Gonlachanvit S, Ghoshal UC, Wu JCY, Siah KTH, Hou X, Oshima T, Choi MY, Lee KJ; Korean Society of Neurogastroenterology and Motility. 2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2021;27:453-81. [PMID: 34642267 DOI: 10.5056/jnm21077] [Reference Citation Analysis]
35 Kröner PT, Cortés P, Lukens FJ. The Medical Management of Gastroesophageal Reflux Disease: A Narrative Review. J Prim Care Community Health 2021;12:21501327211046736. [PMID: 34581222 DOI: 10.1177/21501327211046736] [Reference Citation Analysis]
36 Mössner J. The Indications, Applications, and Risks of Proton Pump Inhibitors. Dtsch Arztebl Int 2016;113:477-83. [PMID: 27476707 DOI: 10.3238/arztebl.2016.0477] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
37 Leary PJ, Barr RG, Bluemke DA, Bristow MR, Kronmal RA, Lima JA, Ralph DD, Ventetuolo CE, Kawut SM. H2 receptor antagonists and right ventricular morphology: the MESA right ventricle study. Ann Am Thorac Soc 2014;11:1379-86. [PMID: 25295642 DOI: 10.1513/AnnalsATS.201407-344OC] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]